Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» This Is the Most Important Number From Novavax's Q1 Earnings
This Is the Most Important Number From Novavax's Q1 Earnings
This Is the Most Important Number From Novavax's Q1 Earnings
Submitted by
admin
on May 13, 2022 - 10:40am
Source:
Motley Fool
News Tags:
Novavax
earnings
vaccines
COVID-19
Headline:
This Is the Most Important Number From Novavax's Q1 Earnings
snippet:
Novavax reported its first-ever profit in its most recent quarterly results.
Sales from its vaccine totaled $586 million and were behind the strong numbers.
But investors need to look deeper and avoid relying on just the top and bottom lines.
Do Not Allow Advertisers to Use My Personal information